View Cart  

PhRMA Asks Supreme Court to Reverse Third Circuit’s ‘Rogue’ Anti-Pay-for-Delay Decision

A A
PhRMA is asking the Supreme Court to take up and overturn the 3rd Circuit Court’s decision that reverse patent settlements between generics and branded drug makers violate antitrust law.

To View This Article:

Login

Subscribe To Drug Industry Daily